MERCK LIFE SCIENCE UK LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. MERCK LIFE SCIENCE UK LIMITED 2020-06-25 → present
2. MERCK CHEMICALS LTD 2002-06-28 → 2020-06-25
3. BDH LIMITED 1986-03-06 → 2002-06-28
4. B D H CHEMICALS LIMITED 1960-05-25 → 1986-03-06

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Deloitte LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The financial statements have been prepared on a going concern basis which the directors consider to be appropriate for the following reasons. The Directors have prepared cash flow forecasts covering at least 12 months from the date of signing these financial statements. The company will have sufficient funds through its central cash pooling account to meet its liabilities as they fall due for that period. In preparing these forecasts, they have taken a prudent approach, in which the average margin for the past three years has been used, where this is lower than the margin achieved for the last 12 months. They also noted that the company has a positive net assets and positive net current assets position as at the balance sheet date.”

Group structure

1. MERCK LIFE SCIENCE UK LIMITED · parent
   1. Merck Performance Materials Limited 100% · UK · provision of research and development services to associated companies.

Significant events

• “One such principal decision made in 2025 was the annual decision made regarding Dividend payments. After consideration of the long-term view and the desire to maintain relationships and good business reputation, it was concluded by the Directors and internal stakeholders including the CFO, Head of Financial Risk and Governance and Group Treasury team that there would be no dividend paid out in 2025.”
• “An additional principal decision taken in 2025 was to deregister the Irish Branch, this decision was taken as the company is no longer in operation after the completion of the final sales in September 2025. The intention is to legally close the Irish Branch business in 2026.”
• “A further principal decision made in 2025 was to merge three existing UK defined benefit pension schemes into one. A merger agreement was signed, effective on November 28th, 2025, to transfer the members, assets and liabilities of the Sigma-Aldrich Pension Scheme and Millipore Pension Investment Plan into the Merck Pension Scheme.”
• “In 2025 all UK employees continued to have the option to provide a monetary donation or contribute items to a physical food bank in all UK sites throughout the month of November. All monetary donations received from Merck Life Science UK employees in 2025 were given to The Trussell Trust, a nonprofit organization whose mission is to work together to ensure no one in the UK needs a food bank to survive, while providing emergency support for people left without enough money to live on.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

2

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.